<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1196</article-id><article-id pub-id-type="doi">10.15690/vramn1196</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SURGERY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ХИРУРГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The lasers in urology</article-title><trans-title-group xml:lang="ru"><trans-title>Лазеры в урологии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7169-2209</contrib-id><name-alternatives><name xml:lang="en"><surname>Enikeev</surname><given-names>Dmitry V.</given-names></name><name xml:lang="ru"><surname>Еникеев</surname><given-names>Дмитрий Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD</p></bio><bio xml:lang="ru"><p>д.м.н.</p></bio><email>katyalaukhtina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8953-0272</contrib-id><contrib-id contrib-id-type="spin">6152-0962</contrib-id><name-alternatives><name xml:lang="en"><surname>Laughtin</surname><given-names>Ekaterina А.</given-names></name><name xml:lang="ru"><surname>Лаухтина</surname><given-names>Екатерина Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>katyalaukhtina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6625-5901</contrib-id><contrib-id contrib-id-type="spin">2537-8189</contrib-id><name-alternatives><name xml:lang="en"><surname>Arshiev</surname><given-names>Magomed R.</given-names></name><name xml:lang="ru"><surname>Аршиев</surname><given-names>Магомед Русланович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>arshmag10@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4369-173X</contrib-id><contrib-id contrib-id-type="spin">1575-3223</contrib-id><name-alternatives><name xml:lang="en"><surname>Taratkin</surname><given-names>Mark S.</given-names></name><name xml:lang="ru"><surname>Тараткин</surname><given-names>Марк Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>marktaratkin@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2937-0983</contrib-id><contrib-id contrib-id-type="spin">9138-1889</contrib-id><name-alternatives><name xml:lang="en"><surname>Alyaev</surname><given-names>Yuri G.</given-names></name><name xml:lang="ru"><surname>Аляев</surname><given-names>Юрий Геннадьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, член-корр. РАН</p></bio><email>ugalyaev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7787-1240</contrib-id><contrib-id contrib-id-type="spin">1470-1850</contrib-id><name-alternatives><name xml:lang="en"><surname>Rapoport</surname><given-names>Leonid M.</given-names></name><name xml:lang="ru"><surname>Рапопорт</surname><given-names>Леонид Михайлович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>leonidrapoport@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5541-2251</contrib-id><name-alternatives><name xml:lang="en"><surname>Glybochko</surname><given-names>Petr V.</given-names></name><name xml:lang="ru"><surname>Глыбочко</surname><given-names>Петр Витальевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, академик РАН</p></bio><email>rektorat@mma.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2020-05-31" publication-format="electronic"><day>31</day><month>05</month><year>2020</year></pub-date><pub-date date-type="pub" iso-8601-date="2020-06-18" publication-format="electronic"><day>18</day><month>06</month><year>2020</year></pub-date><volume>75</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>162</fpage><lpage>168</lpage><history><date date-type="received" iso-8601-date="2019-09-05"><day>05</day><month>09</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-04-23"><day>23</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Издательство "Педиатръ"</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2021-06-18"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnikramn.spr-journal.ru/jour/about/submissions</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/1196">https://vestnikramn.spr-journal.ru/jour/article/view/1196</self-uri><abstract xml:lang="en"><p>A very rapid development of laser technology lead to the fact that many of them have already replaced surgeons with their usual scalpel. Laser technology has taken a place among the methods of treatment of various urological diseases. The features of the physical effect of laser exposure make it possible to characterize laser surgery as safe for the patient and convenient for the doctor. Therefore, along with the improvement of old laser devices, also the development and testing of new ones is constantly carried out. Nowadays the most commonly used lasers in urology are Nd:YAG, Greenlight, diode, Ho:YAG, Tm:YAG lasers and novel thulium fiber laser (TFL). Laser technology is taking place among the recommended methods for the diagnosis and treatment of various urological diseases, such as benign prostatic hyperplasia, urolithiasis, and bladder tumors. The aim of our review was to talk about laser devices that have already taken a place in the arsenal of urologist and about the most interesting developments in the field of laser surgery.</p></abstract><trans-abstract xml:lang="ru"><p>С момента внедрения лазерных технологий в медицину многие из них заменили хирургам привычный скальпель. Лазеры также нашли свое применение почти во всех направлениях урологии. Особенности физического воздействия лазерного излучения (коагуляция, достаточные гемостаз и режущие свойства) позволяют характеризовать лазерные операции как безопасные для пациента и удобные для врача, поэтому постоянно проводится не только усовершенствование старых лазерных аппаратов, но и разработка и испытание новых. На сегодняшний день наиболее известные аппараты в урологии ― это неодимовый лазер (Nd:YAG), зеленый лазер (Greenlight), диодные лазеры, гольмиевый лазер (Ho:YAG), тулиевый лазер (Tm:YAG) и новый отечественный тулиевый волоконный лазер (TFL). Лазерные технологии прочно занимают свое место среди рекомендуемых методик диагностики и лечения различных урологических заболеваний, таких как доброкачественная гиперплазия предстательной железы, мочекаменная болезнь, опухоли мочевого пузыря. Наряду с этим проводятся лабораторные исследования по применению лазеров в области лапароскопической хирургии и фокальной абляции опухоли простаты. Цель нашей работы ― рассказать об устройствах, уже занявших свое место в арсенале уролога, и о наиболее интересных разработках в области лазерной хирургии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>lithotripsy</kwd><kwd>laser</kwd><kwd>BPH</kwd><kwd>kidney</kwd><kwd>bladder</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лазер</kwd><kwd>доброкачественная гиперплазия предстательной железы</kwd><kwd>лазерная энуклеация</kwd><kwd>литотрипсия</kwd><kwd>опухоль мочевого пузыря</kwd></kwd-group><funding-group><award-group><award-id>Array</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Gross AJ, Herrmann TR. History of lasers. World J Urol. 2007;25(3):217−220. doi: 10.1007/s00345-007-0173-8.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Schawlow AL. Facts. Nobel Media AB 2014 [cited 2017 4 Jan 2017]. Available from: http://www.nobelprize.org/nobel_prizes/physics/laureates/1981/schawlow-facts.html.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Geusic JE, Marcos HM, van Uitert LG. Laser oscilations in Nd-doped yttrium aluminium, yttrium gallium and gadolinium garnets. Appl Phys Lett. 1964;4(10):182−184. doi: 10.1063/1.1753928.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Mulvaney WP, Beck CW. The laser beam in urology. J Urol. 1968;99(1):112−115. doi: 10.1016/s0022-5347(17)62652-1.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ашраф Ахмед Али. Трансуретральная лазерная хирургия при доброкачественной гиперплазии предстательной железы: Автореф. дис. … канд. мед. наук. ― СПб., 2003. ― 15 с. [Ashraf Akhmed Ali. Transuretral’naya lazernaya khirurgiya pri dobrokachestvennoy giperplazii predstatel’noy zhelezy. [dissertation abstract] Saint Petersburg; 2003. 15 р. (In Russ).] Доступно по: https://search.rsl.ru/ru/record/01002658995. Ссылка активна на 14.01.2020.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Teichmann HO, Herrmann TR, Bach T. Technical aspects of lasers in urology. World J Urol. 2007;25(3):221−225. doi: 10.1007/s00345-007-0184-5.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Bach T, Herrmann TR, Ganzer R, et al. RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol. 2007;25(3):257–262. doi: 10.1007/s00345-007-0171-x.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Камалов А.А., Осмоловский Б.Е. Трансуретральная фотоселективная лазерная вапоризация в лечении аденомы предстательной железы // Урология. — 2008. — №5. — C. 28–31. [Kamalov AA, Osmolovsky BE. Transurethral photoselective laser vaporization in the treatment of prostatic adenoma. Urologiia. 2008;(5):28–31. (In Russ).]</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Cornu JN, Ahyai S, Bachmann A, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67(6):1066−1096. doi: 10.1016/j.eururo.2014.06.017.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Misrai V, Roupret M, Guillotreau J, et al. [Greenlight (R) photoselective vaporisation for benign prostatic hyperplasia: a systematic review. (In French)]. Prog Urol. 2013;23(2):77−87. doi: 10.1016/j.purol.2012.10.013.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Gilling PJ, Cass CB, Malcolm AR, et al. Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol. 1995;9(2):151−153. doi: 10.1089/end.1995.9.151.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Gilling PJ, Wilson LC, King CJ, et al. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012;109(3):408−411. doi: 10.1111/j.1464-410X.2011.10359.x.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Pirola GM, Saredi G, Codas Duarte R, et al. Holmium laser versus thulium laser enucleation of the prostate: a matched-pair analysis from two centers. Ther Adv Urol. 2018;10(8):223−233. doi: 10.1177/1756287218779784.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Zhang J, Wang X, Zhang Y, et al. 1470 nm Diode laser enucleation vs plasmakinetic resection of the prostate for benign prostatic hyperplasia: a randomized study. J Endourol. 2018;33(3):211−217. doi: 10.1089/end.2018.0499.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Teichmann HO, Herrmann TR, Bach T. Technical aspects of lasers in urology. World J Urol. 2007;25(3):221−225. doi: 10.1007/s00345-007-0184-5.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol. 2005;19(1):25−31. doi: 10.1089/end.2005.19.25.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Enikeev D, Glybochko P, Okhunov Z, et al. Retrospective analysis of short-term outcomes after monopolar versus laser endoscopic enucleation of the prostate: a single center experience. J Endourol. 2018;32(5):417−423. doi: 10.1089/end.2017.0898.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Becker B, Netsch C, Glybochko P, et al. A feasibility study utilizing the thulium and holmium laser in patients for the treatment of recurrent benign prostatic hyperplasia after previous prostatic surgery. Urol Int. 2018;101(2):212−218. doi: 10.1159/000489858.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Dretler SP, Watson G, Parrish JA, et al. Pulsed dye laser fragmentation of ureteral calculi: initial clinical experience. J Urol. 1987;137(3):386−389. doi: 10.1016/s0022-5347(17)44043-2.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Lee J, Gianduzzo TR. Advances in laser technology in urology. Urol Clin North Am. 2009;36(2):189−198. doi: 10.1016/j.ucl.2009.02.004.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Teichman JM, Rao RD, Rogenes VJ, et al. Ureteroscopic management of ureteral calculi: electrohydraulic versus holmium:YAG lithotripsy. J Urol. 1997;158(4):1357−1361. doi: 10.1016/s0022-5347(01)64214-9.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Mi Y, Ren K, Pan H, et al. Flexible ureterorenoscopy (F-URS) with holmium laser versus extracorporeal shock wave lithotripsy (ESWL) for treatment of renal stone &lt; 2 cm: a meta-analysis. Urolithiasis. 2016;44(4):353−365. doi: 10.1007/s00240-015-0832-y.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Гордиенко А.Ю., Мартов А.Г., Андронов А.С., и др. Перкутанная и трансуретральная эндоскопическая хирургия крупных камней верхней трети мочеточника // Вестник Российского научного центра рентгенорадиологии Минздрава России. — 2011. — №11-4. — С. 115–127. [Gordienko А, Martov A, Andronov A, et al. Рercutaneous and transurethral endoscopic surgery for large proximal ureteral stones. Vestnik Rossiiskogo nauchnogo centra rentgenoradiologii Minzdrava Rossii. 2011;(11-4):115–127. (In Russ).]</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Попков В.М., Фомкин Р.Н., Понукалин А.Н., Блюмберг Б.И. Современные аспекты лечения уретеролитиаза. Краткая история возникновения и развития контактной литотрипсии // Саратовский научно-медицинский журнал. — 2011. — Т.7. — №S2. — С. 66–70. [Popkov VM, Fomkin RN, Ponukalin AN, Blumberg BI. Modern aspects of the treatment of ureterolithiasis. A brief history of the occurrence and development of contact lithotripsy. Saratov journal of medical scientific research. 2011;7(S2):66–70. (In Russ).]</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Ventimiglia E, Traxer OR. What is moses effect: a historical perspective. J Endourol. 2019;33(5):353−357. doi: 10.1089/end.2019.0012.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Traxer OR, Keller EX. Thulium fiber laser: the new player for kidney stone treatment? A comparison with Holmium:YAG laser. World J Urol. 2019. doi: 10.1007/s00345-019-02654-5.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Blackmon RL, Fried NM, Irby PB. Comparison of holmium:YAG and thulium fiber laser lithotripsy: ablation thresholds, ablation rates, and retropulsion effects. J Biomed Opt. 2011;16(7):1−6. doi: 10.1117/1.3564884.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Hardy LA, Vinnichenko V, Fried NM. High power holmium:YAG versus thulium fiber laser treatment of kidney stones in dusting mode: ablation rate and fragment size studies. Lasers Surg Med. 2019;51(6):522−530. doi: 10.1002/lsm.23057.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Andreeva V, Vinarov A, Yaroslavsky I, et al. Preclinical comparison of superpulse thulium fiber laser and a holmium:YAG laser for lithotripsy. World J Urol. 2019;38(2):497−503. doi: 10.1007/s00345-019-02785-9.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Traxer OR, Tsarichenko D, Dymov A, et al. V03-02 FIRST clinical study on superpulse thulium fiber laser for lithotripsy. J Urol. 2018;199(4S):e321−e322. doi: 10.1016/j.juro.2018.02.827.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234−241. doi: 10.1016/j.eururo.2012.07.033.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Babjuk M, Burger M, Compérat E, et al. European Association of Urology (EAU) guidelines on non-muscle-invasive bladder cancer (Ta, T1, and CIS). EAU; 2018. Available from: https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Mariappan P, Zachou A, Grigor KM. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010;57(5):843−849. doi: 10.1016/j.eururo.2009.05.047.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Saito S. Transurethral en-bloc resection of bladder tumors. J Urol. 2001;166(6):2148−2150.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Wolters M, Kramer MW, Becker JU, et al. Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol. 2011;29(4):429−432. doi: 10.1007/s00345-011-0686-z.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Li K, Xu Y, Tan M, et al. A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer. Lasers Med Sci. 2019;34(1):85−92. doi: 10.1007/s10103-018-2604-8.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Kramer MW, Wolters M, Herrmann TR. En bloc resection of bladder tumors: ready for prime time? Eur Urol. 2016;69(5):967−968. doi: 10.1016/j.eururo.2016.01.004.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Barzilay B, Lijovetzky G, Shapiro A, et al. The clinical use of CO2 laser beam in the surgery of kidney parenchyma. Lasers Surg Med. 1982;2(1):81−87. doi: 10.1002/lsm.1900020110.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Malloy TR, Schultz RE, Wein AJ, et al. Renal preservation utilizing neodymium:YAG laser. Urology. 1986;27(2):99−103. doi: 10.1016/0090-4295(86)90363-8.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Патент РФ на изобретение RU № 2584080C1. Корепанов В.И. Применение Nd:YAG-лазера в хирургической клинике. [Patent RUS № 2584080C1. Korepanov VI. Primeneniye Nd:YAG-lazera v khirurgicheskoy klinike. (In Russ).] Доступно по: https://yandex.ru/patents/doc/RU2584080C1_20160520. Ссылка активна на 14.01.2020.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Lotan Y, Gettman MT, Ogan K, et al. Clinical use of the holmium: YAG laser in laparoscopic partial nephrectomy. J Endourol. 2002;16(5):289−292. doi: 10.1089/089277902760102767.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Knezevic N, Kulis T, Maric M, et al. Laparoscopic partial nephrectomy with diode laser: a promising technique. Photomed Laser Surg. 2014;32(2):101−105. doi: 10.1089/pho.2013.3646.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Thomas AZ, Smyth L, Hennessey D, et al. Zero ischemia laparoscopic partial thulium laser nephrectomy. J Endourol. 2013;27(11):1366−1370. doi: 10.1089/end.2012.0527.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Lindner U, Weersink RA, Haider MA, et al. Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol. 2009;182(4):1371−1377. doi: 10.1016/j.juro.2009.06.035.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Oto A, Sethi I, Karczmar G, et al. MR imaging-guided focal laser ablation for prostate cancer: phase I trial. Radiology. 2013;267(3):932−940. doi: 10.1148/radiol.13121652.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Van der Poel HG, van den Bergh RC, Briers E, et al. Focal therapy in primary localised prostate cancer: the European association of urology position in 2018. Eur Urol. 2018;74(1):84−91. doi: 10.1016/j.eururo.2018.01.001.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Lovisolo JA, Legramandi CP, Fonte A. Thermal ablation of small renal tumors − present status. Scientific World J. 2007;7:756−767. doi: 10.1100/tsw.2007.144.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>De Jode MG, Vale JA, Gedroyc WM. MR-guided laser thermoablation of inoperable renal tumors in an open-configuration interventional MR scanner: preliminary clinical experience in three cases. J Magn Reson Imaging. 1999;10(4):545−549. doi: 10.1002/(sici)1522-2586(199910)10:4&lt;545::aid-jmri7&gt;3.0.co;2-r.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Thomas RW, Herrmann EN, Nagel U, et al. EAU guidelines on laser technologies. Eur Urol. 2012;61(4):783−795. doi: 10.1016/j.eururo.2012.01.010.</mixed-citation></ref></ref-list></back></article>
